Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS-CoV-2 (COVID-19) Severe Pneumonia”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04962893
What this trial is testing

Study of a Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine

Who this might be right for
Covid19
Ihsan GURSEL, PhD, Prof. 349
Early research (Phase 1)Ended earlyNCT05386472
What this trial is testing

Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19

Who this might be right for
COVID-19
Pfizer 25
Large-scale testing (Phase 3)Study completedNCT04552379
What this trial is testing

The Containing Coronavirus Disease 19 (COVID-19) Trial

Who this might be right for
SARS-CoV InfectionInterferonCovid19
Pontificia Universidad Catolica de Chile 1,173
Not applicableStudy completedNCT04351503
What this trial is testing

A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19

Who this might be right for
SARS Coronavirus (SARS-CoV-2) Infection
University Hospital, Basel, Switzerland 126,586
Large-scale testing (Phase 3)Study completedNCT05780424
What this trial is testing

BRII-196/BRII-198 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 353
Not applicableStudy completedNCT04651413
What this trial is testing

PCR Cycle Threshold Values and COVID-19 Outcomes

Who this might be right for
Covid19
University Hospitals of North Midlands NHS Trust 934
Not applicableNo Longer AvailableNCT04358588
What this trial is testing

Pulsed Inhaled Nitric Oxide for the Treatment of Patients With Mild or Moderate COVID-19

Who this might be right for
Coronavirus InfectionCOVID-19Pneumonia, Viral
Bellerophon
Not applicableNo Longer AvailableNCT04420988
What this trial is testing

Investigational COVID-19 Convalescent Plasma Infusion for Severely or Life-threateningly Ill COVID-19 Patients

Who this might be right for
COVID-19SARS-CoV 2SARS-CoV Infection
Rutgers, The State University of New Jersey
Not applicableStudy completedNCT04613817
What this trial is testing

Sero-prevalence COVID-19 Among Belgian Children

Who this might be right for
SARS-CoV-2SARS-CoV InfectionCovid19
Sciensano 2,103
Testing effectiveness (Phase 2)Study completedNCT05438602
What this trial is testing

Learn About the Study Medicines (Nirmatrelvir Plus Ritonavir) in People Aged 12 Years or Older With COVID-19 and a Compromised Immune System

Who this might be right for
COVID-19
Pfizer 158
Testing effectiveness (Phase 2)UnknownNCT04355429
What this trial is testing

Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID)

Who this might be right for
PneumoniaCoronavirus InfectionCOVID-19
Assistance Publique - Hôpitaux de Paris 230
Not applicableStudy completedNCT05323851
What this trial is testing

How Future Surgery Will Benefit From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Related Measures Perspective From Italian Young Surgeon Society (SPIGC)

Who this might be right for
COVID-19Health Behavior
University of Rome Tor Vergata 581
Not applicableStudy completedNCT04452422
What this trial is testing

Deep Venous Thrombosis in Non-severe COVID-19 Patients Hospitalized for a Neurovascular Pathology

Who this might be right for
Deep Venous Thrombosis
University Hospital, Strasbourg, France 30
Testing effectiveness (Phase 2)Study completedNCT05142553
What this trial is testing

Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration.

Who this might be right for
COVID-19SARS-CoV-2 Acute Respiratory Disease
Hipra Scientific, S.L.U 887
Not applicableUnknownNCT04441372
What this trial is testing

Prognostication of Oxygen Requirement in Non-severe SARS-CoV-2 Infection

Who this might be right for
SARS-CoV2COVID
Medecins Sans Frontieres, Spain 600
Large-scale testing (Phase 3)UnknownNCT04597775
What this trial is testing

Chemoprevention Clinical Trial of COVID-19: Hydroxychloroquine Post Exposure Prophylaxis

Who this might be right for
SARS-CoV Infection
Regional Center for Disease Control and Prevention, Jordan 93
Early research (Phase 1)Study completedNCT05938075
What this trial is testing

Study of VXCO-100, a SARS-CoV Candidate Vaccine, in Adults in the Republic of South Africa

Who this might be right for
SARS-CoVSARS-CoV-2
Vaccine Company, Inc. 130
Large-scale testing (Phase 3)Ended earlyNCT04421664
What this trial is testing

Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada)

Who this might be right for
Corona Virus InfectionSARS-CoV InfectionCoronavirus
McGill University Health Centre/Research Institute of the McGill University Health Centre 70
Not applicableStudy completedNCT04359706
What this trial is testing

Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With COVID-19

Who this might be right for
Sars-CoV2
University Hospital, Lille 34
Large-scale testing (Phase 3)Study completedNCT06409663
What this trial is testing

A Strain Change Study for SARS-CoV-2 rS Vaccines

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Novavax 60
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation